Metal ion-dependent, reversible, protein filament formation by designed beta-roll polypeptides by Scotter, Andrew J et al.
BioMed  Central
Page 1 of 13
(page number not for citation purposes)
BMC Structural Biology
Open Access Research article
Metal ion-dependent, reversible, protein filament formation by 
designed beta-roll polypeptides
Andrew J Scotter1,2, Meng Guo1,3,4, Melanie M Tomczak1,2, 
Margaret E Daley1,5, Robert L Campbell1,2, Richard J Oko6, 
David A Bateman1,3,4, Avijit Chakrabartty1,3,4, Brian D Sykes1,5 and 
Peter L Davies*1,2
Address: 1Protein Engineering Network Centres of Excellence, 750 Heritage Medical Research Centre, Edmonton, AB, T6G 2S2, Canada, 
2Department of Biochemistry, Queen's University, Kingston, ON, K7L 3N6, Canada, 3Department of Medical Biophysics, University of Toronto, 
ON, M5G 2M9, Canada, 4Ontario Cancer Institute, University of Toronto, ON, M5G 2M9, Canada, 5Department of Biochemistry, University of 
Alberta, Edmonton, AB, 6G 2H7, Canada and 6Department of Anatomy and Cell Biology, Queen's University, Kingston, Ontario, K7L 3N6, 
Canada
Email: Andrew J Scotter - scottera@post.queensu.ca; Meng Guo - guomeng@hotmail.com; Melanie M Tomczak - melanietca@yahoo.ca; 
Margaret E Daley - mdaley@u.washington.edu; Robert L Campbell - rlc1@post.queensu.ca; Richard J Oko - ro3@post.queensu.ca; 
David A Bateman - dbateman@uhnres.utoronto.ca; Avijit Chakrabartty - chakrab@uhnres.utoronto.ca; Brian D Sykes - brian.sykes@ualberta.ca; 
Peter L Davies* - peter.davies@queensu.ca
* Corresponding author    
Abstract
Background: A right-handed, calcium-dependent β-roll structure found in secreted proteases and
repeat-in-toxin proteins was used as a template for the design of minimal, soluble, monomeric
polypeptides that would fold in the presence of Ca2+. Two polypeptides were synthesised to
contain two and four metal-binding sites, respectively, and exploit stacked tryptophan pairs to
stabilise the fold and report on the conformational state of the polypeptide.
Results:  Initial analysis of the two polypeptides in the presence of calcium suggested the
polypeptides were disordered. The addition of lanthanum to these peptides caused aggregation.
Upon further study by right angle light scattering and electron microscopy, the aggregates were
identified as ordered protein filaments that required lanthanum to polymerize. These filaments
could be disassembled by the addition of a chelating agent. A simple head-to-tail model is proposed
for filament formation that explains the metal ion-dependency. The model is supported by the
capping of one of the polypeptides with biotin, which disrupts filament formation and provides the
ability to control the average length of the filaments.
Conclusion: Metal ion-dependent, reversible protein filament formation is demonstrated for two
designed polypeptides. The polypeptides form filaments that are approximately 3 nm in diameter
and several hundred nm in length. They are not amyloid-like in nature as demonstrated by their
behaviour in the presence of congo red and thioflavin T. A capping strategy allows for the control
of filament length and for potential applications including the "decoration" of a protein filament with
various functional moieties.
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Background
There are many types of protein folding motifs formed by
simple repetitive sequences, or so-called solenoid proteins
[1]. One example is the β-roll motif, which at its most
basic, is a repeating unit of a short β-strand linked to a sec-
ond short beta-strand by a turn region comprising two
approximately 90 degree bends in the polypeptide back-
bone. This unit then repeats as another turn region links
further β-strands into the unit forming a stack of parallel
β-sheets, one on either side of the β-roll motif. An exam-
ple of such a motif from the X-ray structure of Pseudomonas
aeruginosa alkaline protease is presented in Figure 1. The
simple relationship between sequence and protein struc-
ture of solenoid proteins including β-roll, β-helical, leu-
cine-rich repeat and ankyrin repeat proteins has been well
documented previously [1]. β-roll containing protein
folds have also been reviewed previously so only a short
introduction is given here [2,3].
It has also previously been put forward that parallel β-
strands and β-helical or β-roll repeating motifs are found
in many amyloid filaments and fibrils [2]. To date, the β-
roll model of HET-s fibrils from Podospora anserina [4] is
the most plausible β-roll-like model of an amyloid fila-
ment and has been supported by recent electron miscros-
copy studies [5] in addition to mutational analysis of
HET-s derived protein sequences.
β-roll domains have been found in a number of proteins,
often as a subdomain that binds divalent metal ions
(Ca2+), as in the "zincin" family of metalloproteases [6-8].
including alkaline protease from Pseudomonas aeruginosa,
see Figure 1 to indicate the position of the β-roll domain
within the protease[7]. This β-roll is composed of glycine-
and aspartate-rich nonapeptide repeats with a GGXG(X/
D)DXUX consensus sequence (where G = glycine, X = any
amino acid, D = aspartate, and U = a large hydrophobic
residue such as Leu, Ile, Val, Phe, Tyr) [7].
Similar nonapeptide repeats are present in the C-terminal
regions of the 100 – 200 kDa repeat-in-toxin (RTX) family
of cytotoxic and hemolytic toxins from Gram negative
bacteria [9-15] and the I.3 family of lipases [16,17]. In
addition, a right-handed β-roll domain containing non-
apeptide repeats has been structurally characterized in the
R-module of the AlgE4 C-5 epimerase from Azotobacter
vinelandii  by nuclear magnetic resonance (NMR) [18].
Structural and experimental data suggest that calcium ions
can be bound within the turns of the R-module β-roll
domain to stabilize the overall protein.
The RTX metal-binding nonapeptide repeat has been the
subject of two previous studies that exploit the change in
conformation of the motif upon calcium binding. A study
by Lilie et al. used a synthetic 75-residue polypeptide
(NH2-WLS [GGSGNDNLS]8-COOH) as a minimized
model of the β-roll domains from RTX toxins [19]. The
synthetic β-roll irreversibly bound calcium in the milli-
molar range and showed a change in conformation in the
presence of 100 mM CaCl2 and 25% PEG 8000 as moni-
tored by far-UV circular dichroism (CD). The minimized
β-roll behaved similarly to the β-roll regions of B. pertusis
adenylate cyclase toxin and E. coli hemolysin. The early
success of minimizing the β-roll domain was followed by
a study using the GGXGXDXUX nonapeptide repeat β-roll
motif from Serratia marcescens serralysin as a calcium
switching "molecular spring" fused between two 6-phos-
pho-β-galactosidase (PGAL) monomers [20]. In the pres-
ence of calcium, the β-roll formed a 2 nm long rod linking
the two PGAL units, similar to a molecular dumbbell
when viewed by electron microscopy (EM). Upon addi-
tion of ethylenediaminetetraacetic acid (EDTA) the β-roll
adopted an extended conformation and the two PGAL
units became more distant from one another as demon-
strated by EM.
The crystal structure of alkaline protease from Pseudomonas  aeruginosa (1KAP) to 1.64 Å and the β-roll domain in isola- tion Figure 1
The crystal structure of alkaline protease from Pseu-
domonas aeruginosa (1KAP) to 1.64 Å and the β-roll 
domain in isolation. A) Full structure of the zinc metallo-
protease [7] showing the zinc atom coordinated in the active 
site (blue sphere) and the calcium binding β-roll circled in 
black; B) Enlarged view looking down the axis of the β-roll of 
alkaline protease including the five bound calcium ions 
(orange spheres), the parallel β-strands and tight turns 
around the metal-binding sites and the side chains of the 
seven residues making contact with Ca2+ ions: Asp338, 
Asn347, Asp356, Asp365, Asp374, Asp 390 and Asp400; C) 
Enlarged view of the front face of the β-roll of alkaline pro-
tease with the same residues highlighted as in panel B.BMC Structural Biology 2007, 7:63 http://www.biomedcentral.com/1472-6807/7/63
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The success of the above β-roll models inspired our design
of two Beta-Roll Designed polypeptides (BRD1 and 2)
based on the nonapeptide consensus sequence from alka-
line protease [9]. An alignment of the amino acid
sequences of alkaline protease, BRD1 and BRD2 is pre-
sented in Figure 2A. In the X-ray structure of alkaline pro-
tease from P. aeruginosa [7] there are a total of seven
nonapeptide repeats that together bind five Ca2+ ions to
form a right-handed β-roll with three parallel β-strands on
each side of the motif (Figure 1). The repeats form short
β-strands (4–5 residues) linked by tight turns where aspar-
tate side chains, peptide backbone carbonyl groups and
water molecules bind Ca2+ ions internally to stabilize the
motif. The Ca2+ ions are generally sandwiched between
two neighbouring turn regions which each contribute a
side chain carbonyl group to the coordination. In addi-
tion, three to five backbone carbonyl groups, and one or
two water molecules complete a six-coordinate (approxi-
mately octahedral) binding site.
BRD 1 was designed as a 34-amino-acid minimized β-roll
motif containing three β-strands and two calcium-binding
sites, see Figure 2B and 2C. BRD1 was intended to be sta-
bilized by the coordination of two metal ions and the
introduction of a pair of stacked tryptophan residues
(W16 and W34), which have previously been shown to
stabilize short, soluble, β-hairpin proteins [21]. Residues
9 (I to K) and 27 (Y to E) of BRD1 were altered from the
alkaline protease sequence to introduce a potential salt
bridge between β-strands. BRD2 is an elongated version of
BRD1 (50 amino acids) that is comprised of five β-strands
with four calcium-binding sites, and also includes a
stacked pair of tryptophan residues (W27 and W45) as
shown in Figure 2D and 2E. Once again charged residues
were introduced to the sequence (L to Q at position 16
and I to K at position 34) to promote stability and solubil-
ity. The N-terminal extension contains a modified non-
apeptide repeat with asparagine side chains to potentially
bind calcium and a glutamic acid residue to add further
charged character to the polypeptide. Several glycine resi-
dues were replaced with alanine to limit the flexibility of
the BRD2 polypeptide. The folded BRD2 motif is approx-
imately 30 Å wide, 25 Å deep and 15 Å high.
The BRD polypeptides were originally designed to fold
upon the addition of calcium and form soluble mono-
meric β-rolls that could be used as scaffolds for the protein
engineering of various functions including ice binding
mimicking insect antifreeze proteins. However, the data
presented below demonstrate that the BRD polypeptides
undergo ordered and reversible metal ion-dependent pro-
tein polymerization in the presence of lanthanum ions.
The process generates very long, thin, unbranched fila-
ments that exhibit similarities and differences to classical
amyloid fibrils.
Results
La3+ causes ordered aggregation of the BRD polypeptides
Initial analysis by CD and 1-D NMR showed no obvious
conformational change upon the addition of calcium to
the BRD polypeptides as shown in Figure 3. It is clear that
the addition of 10 mM CaCl2 to BRD2 did not change the
conformation of the polypeptide. The CD spectra of BRD2
in Figure 3A are indicative of random coil structure, sug-
gesting that the BRD polypeptides are unstructured even
in the presence of calcium. Figures 3B and 3C show 1D
NMR data for BRD1 in the presence and absence of CaCl2
respectively. The spectra are indicative of an unstructured
peptide, as judged by the narrow line widths and the lack
of spectral dispersion from the expected chemical shifts of
a free peptide. No change was observed as calcium was
added, beyond a small amount of broadening at the high-
est calcium concentrations (~100 mM) indicating possi-
ble aggregation. The intrinsic fluorescence of the stacked
tryptophan pairs was also analyzed and suggested only a
slight change towards a more hydrophobic environment
upon the addition of calcium (not shown), further evi-
dence that the polypeptides were not subject to a signifi-
The amino acid sequence and modeled structures of BRD1  and BRD2 Figure 2
The amino acid sequence and modeled structures of 
BRD1 and BRD2. A) Amino acid sequence alignment of 
the β-roll from P. aeruginosa alkaline protease with BRD1 and 
BRD2, highlighting the GGxGxDxUx repeat. Identical resi-
dues are indicated by an asterisk; B) The modeled structure 
of BRD1 highlighting the pair of tryptophan residues and two 
calcium-binding sites composed of residues Asp6, Asn15, 
Asp24 and Asp33; C) The back face of the BRD1 model 
showing the stacked Trp pair in more detail; D) The mod-
eled structure of BRD2 highlighting the pair of tryptophan 
residues and four calcium-binding sites composed of residues 
Glu6, Asp15, Asp 21, Asn24 and Asp33 and Asp 42; E) The 
back face of the BRD2 model showing the stacked Trp pair in 
more detail.BMC Structural Biology 2007, 7:63 http://www.biomedcentral.com/1472-6807/7/63
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cant conformational change upon the addition of metal
ions.
The trivalent lanthanide metal lanthanum was substituted
for calcium. It has a very similar ionic radius but an addi-
tional charge which enables the ion to occupy calcium-
binding sites with a higher affinity than calcium [22]. The
addition of lanthanum chloride to a solution containing
either BRD polypeptide produced a cloudy suspension
rendering CD, NMR and fluorescence experiments inef-
fective.
The aggregation of the BRD polypeptides was more
closely analyzed using right angle light scattering time-
drive experiments. A summary of the initial experiments
illustrating the lanthanum dependence, BRD polypeptide
specificity and reversibility of the aggregation event is pre-
sented in Figure 4. A very large increase in right angle light
scattering (and therefore particle size in the solution) is
produced by both BRD1 and 2 polypeptides upon addi-
tion of lanthanum (blue and red lines in Figure 4A). The
increase in right angle light scattering occurs at around
10–20 s after the initiation of lanthanum addition (at 500
s) for both BRD polypeptides. The signal is 4-fold higher
for the larger peptide. Calcium addition to solutions of
BRD1 and 2 (green and yellow lines in Figure 4A) does
not increase right angle light scattering. This suggests that
calcium ions are not capable of initiating an aggregation
event. After the lanthanum addition is stopped (at 620 s)
Right angle light scattering timedrive plots for BRD1, 2 and  control peptides/proteins in the presence of calcium or lan- thanum and the maximum right angle light scattering  responses using a variety of metal ions Figure 4
Right angle light scattering timedrive plots for BRD1, 
2 and control peptides/proteins in the presence of 
calcium or lanthanum and the maximum right angle 
light scattering responses using a variety of metal 
ions. The proteins were added at 200 s and the metals were 
introduced using a syringe pump starting at 500 s for a total 
of 120 s. A solution of EDTA was added to the cuvette using 
a syringe pump beginning at 1200 s until the right angle light 
scattering signal fell to its original level. A) Timedrive data 
for BRD1 with calcium (yellow line), BRD1 with lanthanum 
(red line), BRD2 with calcium (green line) and BRD2 with 
lanthanum (blue line). This plot illustrates that an increase in 
right angle light scattering (and therefore filament formation) 
is specific for peptides in solutions containing lanthanum and 
that it is a reversible process. This plot also highlights the 
larger increase in scattering for BRD2 over BRD1 at identical 
concentrations. B) Timedrives for a protein free control 
with lanthanum (purple line), a 15-mer peptide with α-helical 
propensity (red line), CAST (green line) and BRD2 with lan-
thanum (blue line) highlighting that the increase in right angle 
light scattering is specific to the BRD polypeptides only. C) A 
bar chart displaying maximum right angle light scattering 
responses at 320 nm for various metals at 10 mM final con-
centration in solutions containing 100 μM BRD2 peptide.
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the right angle light scattering signal remains fairly con-
stant although it does have a slight positive slope suggest-
ing continued increase in particle size with time. The
addition of EDTA to suspensions of BRD1 or 2 aggregates
at 1200 s immediately halts the gradual increase in right
angle light scattering, after which the loss of right angle
light scattering is accelerated as more EDTA is introduced
into the cuvette (red and blue lines in Figure 4A). This sug-
gests that the increase in particle size is caused directly by
lanthanum and can be reversed by chelating the La3+ ions.
The sharp increase then decrease in scattering at 1450 s
exhibited by BRD1 (red line in Figure 4A) was a generally
observed characteristic of the BRD 1 peptide but was not
observed for BRD2 suspensions. The marked increase in
scattering exhibited by the larger BRD2 peptide relative to
BRD1 at a similar concentration was also consistently
seen.
The addition of lanthanum to other unrelated peptides
and proteins did not produce a significant increase in
right angle light scattering, suggesting that aggregation of
peptides in the presence of lanthanum is not a general
phenomenon (Figure 4B). The controls included a 15-res-
idue peptide corresponding to the N-terminal sequence of
m-calpain (a cysteine protease) large subunit [23] (1578.9
Da) (red line in Figure 4B) and calpastatin (CAST), a rela-
tively unstructured 10.5-kDa protein that specifically
inhibits calpain [24] (green line in Figure 4B). The final
experiment in Figure 4B shows that a peptide-free control
(purple line in Figure 4B) did not produce an increase in
right angle light scattering thereby confirming that the
observed increases for the BRD polypeptides must be the
result of specific peptide-La3+ ion interactions. The addi-
tion of EDTA to these control solutions has no effect on
the scattering signal. Figure 4C highlights the specificity
for lanthanum (blue bar) as other divalent and trivalent
metal ions failed to produce large increases in right angle
light scattering as a result of protein-metal aggregation.
BRD1 and 2 aggregates are protein filaments
Four EM images of BRD1 and 2 peptide filaments and
controls are presented in Figure 5. It is clear from Figure
5A and 5B that smooth peptide filaments are formed by
BRD1 and 2 in the presence of La3+ ions. Bundles of fila-
ments, some showing a tangled topology, can also be
seen. The unbranched and flexible nature of the filaments
is readily apparent. From these EM images it is possible to
estimate the dimensions of the filaments. They vary in
length from only a few hundred nanometers to a few
micrometers, although the exact length is hard to accu-
rately gauge as the filaments overlap each other in long
bundles. The diameter of a single filament appears to be
around 3 nm, though they can be seen to clump and form
bundles that are up to 40 nm thick. The general diameter
of the BRD filaments is similar to that of amyloid protofi-
brils associated with neurodegenerative diseases. How-
ever, the appearance of the BRD1 and 2 filament bundles
are less ordered and much thinner than that of amyloid
fibrils [25].
Figure 5C shows an EM grid that was prepared from a
solution of BRD2 with calcium ions in place of lantha-
num ions and no protein filaments are observed. This
confirms that calcium is not capable of causing the BRD
polypeptides to aggregate into filaments. Figure 5D is an
example of a grid that was prepared from a suspension of
BR2-La3+ filaments but was subsequently treated in situ
with a solution of EDTA. The filaments that were previ-
ously visible have disassociated and are no longer visible
by negative staining. This finding supports the right angle
light scattering observations of EDTA causing filament
dissociation by removing lanthanum ions from the aggre-
gates.
Negative-stained EM images of BRD1 and 2 filaments at  30,000 × magnification on Formvar-coated nickel grids Figure 5
Negative-stained EM images of BRD1 and 2 filaments 
at 30,000 × magnification on Formvar-coated nickel 
grids. A) BRD1 filaments in a lanthanum solution; B) BRD2 
in a lanthanum solution; C) BRD2 in a calcium solution; D) 
BRD2 in a lanthanum solution with EDTA added post fila-
ment formation. The images clearly show that filaments are 
only formed by BRD polypeptides in the presence of lantha-
num and that they can be disassembled by the addition of 
EDTA.BMC Structural Biology 2007, 7:63 http://www.biomedcentral.com/1472-6807/7/63
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Modelling suggests the BRD filaments are head-to-tail 
polymers
If filaments that are several hundred nanometers long can
form, then the interaction between the monomeric units
must be repetitive. Considering the BRD2 peptide, one
obvious area for an interaction between monomers is
between termini to linearly extend the filament. Interac-
tions between the termini could be of a head-to-tail (Fig-
ure 6Ai) or head-to-head variety (Figure 6Aii). The most
likely interaction in a very long polymer would be head-
to-tail as this unit could be repeated indefinitely. A head-
to-head interaction would also require a second, distinct,
tail-to-tail interaction, Figure 6Aii. If the interaction is
between the faces of the BRD polypeptide, a similar case
would occur where there could be a front-to-back interac-
tion that repeats endlessly, see Figure 6Aiii. There could
also be a front-to-front interaction in addition to a back-
to-back interaction but this would position four tryp-
tophan residues in close proximity which is likely to be
unfavourable, as shown in Figure 6Aiv.
Metal ions must also play a part in the interaction and
there are already four designed metal-binding sites in the
turn regions of the monomeric BRD polypeptides. It is
possible that extra lanthanum ions bind between two half
metal binding sites, composed of the Asp and Asn carbo-
nyl groups not already bound to a metal ions and peptide
backbone carbonyls, found in the N and C termini of dif-
ferent monomers, essentially gluing two monomers
together in a head-to-tail fashion. There are two Asn side
chains and one Glu side chain close to the turn regions in
BRD1 and two Asp residues in BRD2 that could form half
metal binding sites near the two termini of the mono-
mers. It is harder to imagine metal ions binding between
faces of BRD monomers as the only carbonyl donors in
this region would be from peptide side chains. The only
external carbonyl containing side chains in BRD1 are
close to the turns as previously mentioned. There are no
external Asp or Glu side chains and only two external Asn
side chains on BRD2, and these are both near the first N-
terminal turn region.
Our prediction is that the BRD monomers interact via a
metal-dependent head-to-tail interaction between the N
and C termini of two different monomers. This is the sim-
plest repeating unit that could form very long polymers.
In addition, the width of such a repeating unit would be
around 3 nm, the width of a single filament measured
from EM images. Two models are proposed for the polym-
erization of BRD2 into a protein filament, as shown in
Figure 6B. The first is a head-to-tail repeating unit where
the front and back faces of BRD2 are always on the same
side which produces a bend in the polymer. The second
model is based on the front and back faces of the BRD
monomer alternating, which causes a twist. These topolo-
gies have been observed by EM. Similar models would
also be feasible for BRD1 polymerization.
Testing the filament model with a capping modification
The simple end-to-end repeating model was tested by syn-
thesizing a modified BRD2 polypeptide that was tagged
with biotin at the N-terminus (BioBRD2). Right angle
light scattering timedrives using BioBRD2 compared to
unmodified BRD2 are presented in Figure 7A. The
increase in scattering response for 10 μM BioBRD2 (yel-
low line) was 10% of the response observed for 10 μM
BRD2 at the same concentration (blue line). This immedi-
ately suggested that the modified BRD2 polypeptide could
not polymerize as well as the unmodified peptide. Sam-
ples of 20 μM (purple line), 30 μM (green line) and 60 μM
BioBRD2 (red line) were also analyzed and a steady
increase in scattering was observed. However, even after a
6-fold increase in concentration the maximum observed
response for BioBRD2 (red line) was only two thirds of
that for 10 μM BRD2 (blue line). Once again, the aggrega-
tion causing an increase in right angle light scattering was
reversible upon addition of EDTA as shown by the drop in
signal beginning at 1200 s and a return to baseline levels
by 1650 s. However, less EDTA was required to reduce
Schematic representations of how BRD2 monomers could  polymerise as long thin filaments Figure 6
Schematic representations of how BRD2 monomers 
could polymerise as long thin filaments. Key: N = N 
terminus, C = C terminus, F = Front Face, B = Back Face. A) 
The models are i) head-to-tail; ii) head-to-head and tail-to-
tail; iii) front face to back face; iv) front face to front face 
and back face to back face. The favoured model for forma-
tion of very long filaments is the head-to-tail formation. B) 
Models of docked BRD2 monomers that are of the correct 
dimensions to form 3 nm diameter filaments that could 
extend over hundreds of nm. i) head-to-tail BRD2 mono-
mers with their front faces all aligned on one side of the fila-
ment creating a bent polymer; ii) head-to-tail BRD2 
monomers with their front faces on alternating sides of the 
filament creating a twisted polymer.
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scattering to the pre-La3+ baseline for the BioBRD2 sam-
ples than for BRD2. Scattering signals were reduced to
baseline levels after 1500 s for the 10–60 μM BioBRD2
samples (yellow, purple, green and red lines, respec-
tively).
The addition of BioBRD2 to BRD2 severely disrupts fila-
ment formation (Figure 7B). Samples all contained a total
peptide concentration of 10 μM but were comprised of a
mixture of BioBRD2 and BRD2 peptides. Samples con-
tained a 1 to 1 (cyan line), 1.5 to 1 (purple line), 4 to 1
(green line) and 9 to 1 (red line) molar excess of unmodi-
fied BRD2. These samples were compared to the BRD2
(blue line) and BioBRD2 (yellow line) data from Figure
7A. Hardly any increase in scattering was observed with
the 1 to 1 mixture of BRD2 to BioBRD2 (cyan line) while
even at 9 to 1 BRD2 to BioBRD2 (red line) the maximum
scattering increase was only 24% of that for the same total
concentration of BRD2 alone (blue line). Intermediate
ratios of the BRD polypeptides showed a slight increase in
scattering in proportion to the amount of BRD2 present
but the increase in scattering was unstable as shown by the
negative slope for each of the datasets.
Further evidence for the disruption of filament formation
by modifying the N-terminus of BRD2 was provided by
EM images of samples containing a range of BRD2 to
BioBRD2 ratios in the presence of lanthanum, which are
summarized in Figure 8. BioBRD2 in lanthanum (Figure
8A) produced no visible filaments while the 2 to 1 mix-
ture of BRD2 to BioBRD2 (Figure 8B) produced only a few
short filaments. Increasing the ratio to 5 to 1, 10 to 1 and
20 to 1 produced an increase in the quantity and length of
filaments observed (See Figure 8C for the 20:1 EM image).
A 40 to 1 excess of BRD2 over BioBRD2 produced fila-
ments that were similar in appearance and almost as long
and abundant as conditions containing only unmodified
BRD2 (Figure 8D and Figure 5B).
Controlling filament length by capping
Data collected by right angle light scattering and EM sug-
gested that the length and abundance of the BRD fila-
ments could be controlled by varying the amount of
BioBRD2 relative to unmodified BRD2. To test this,
dynamic right angle light scattering (DLS) was employed
to analyze the relationship between particle size and the
ratio of BRD2 to BioBRD2. A range of solutions was tested
in triplicate and the average hydrodynamic radius plotted
against the amount of BioBRD2 in the solution as shown
in Figure 9. The inverse relationship between hydrody-
namic radius (and thus particle size) and the amount of
BioBRD2, is pronounced and appears to have two phases.
The initial phase is a linear increase in particle size
between 100% and 50% BioBRD2. Between 50% and
20% BioBRD2 there is little change in hydrodynamic
radius suggesting an equilibrium has been obtained.
Below 50% BioBRD2, the increase in hydrodynamic
radius appears to be more geometric in nature and the
radius is also more variable as displayed by the larger error
bars nearer 0% BioBRD2. DLS data reiterate the right
angle light scattering and EM findings that altering the N
terminus of BRD2 can lead to a method for capping the
filaments, thereby controlling filament length and abun-
dance. This supports our simple model of filament forma-
tion by repeating head-to-tail N to C terminus
interactions.
Right angle light scattering timedrive plots for BRD2,  BioBRD2 and mixtures of the two peptides in the presence  of lanthanum Figure 7
Right angle light scattering timedrive plots for BRD2, 
BioBRD2 and mixtures of the two peptides in the 
presence of lanthanum. The proteins were added at 100 
(BRD2) and 200 s (BioBRD2) and the metals were intro-
duced using a syringe pump starting at 500 s for a total of 120 
s. A solution of EDTA was added to the cuvette using a 
syringe pump beginning at 1200 s until the right angle light 
scattering signal fell to its original level. A) Timedrive illus-
trating the relative right angle light scattering responses of 10 
μM BRD2 (blue line) 10 μM (yellow line), 20 μM (purple 
line), 30 μM (green line) and 60 μM (red line) BioBRD2. It is 
clear that BioBRD2 does not produce increases in right angle 
light scattering comparable to BRD2, suggesting it does not 
form stable filaments. B) Timedrive illustrating the relative 
right angle light scattering responses of 10 μM BRD2 (blue 
line) BioBRD2 alone (yellow line), a 1 to 1 (cyan line), 1.5 to 
1 (purple line), 4 to 1 (green line) and 9 to 1 (red line) excess 
of unmodified BRD2.
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La3+ ions are present in excess over the BRD polypeptides
Amino acid analysis data are summarized in Table 1 and
highlight the close match between experimental and
expected composition of the peptides. Only nine amino
acids are present in appreciable amounts, of which Asx,
Ala, Gly and Leu predominate. There are only trace
amounts of amino acids like Tyr, Phe, Met that do not
appear in the sequence; and Trp, although present in the
sequence, is missing because it is not stable to the condi-
tions used for acid hydrolysis of the peptide. These data
also prove that the filaments are proteinaceous in nature.
Amino acid analysis data also allowed an estimation of
the amount of peptide that aggregates. Compared to val-
ues for the starting solution of BRD2, the pellet and the
remaining supernatant, around 75% of the peptide
formed aggregates. Elemental analysis of the same sam-
ples for La3+ suggested that the pellet contained approxi-
mately 50% of the added lanthanum giving a ratio of La3+
to BRD polypeptide of 75 to 1. This is far from the
expected 4 to 1 ratio. Calculations from the right angle
light scattering data suggest that around 1.0–1.5 μmoles
of lanthanum are added to the cuvette containing 0.03
μmoles of BRD polypeptide. This produces a minimum
ratio of 33 to 1 and a maximum ratio of 50 to 1 La3+ ions
to BRD polypeptide. Attempts were made to wash precip-
itated fibrils to remove unbound or non-specifically
bound La3+. Following resuspension in water and centrif-
ugation, the BRD2 filament pellet decreased in size sug-
Table 1: Amino acid analysis data for BRD2 protein filaments
A) Amino 
Acid
B) Picomoles in 
Sample
C) % of 
Total
D) Expected % in 
BRD2 Seq
Asx 594.2 14.6 18
Glx 222.1 5.8 6
Ser 152.9 4.0 4
Gly 844.0 22.0 20
Ala 1022.0 26.5 26
Val 199.0 5.2 4
Ile 152.1 3.9 4
Leu 588.0 15.2 12
Lys 82.1 2.1 2
3856.4 100 96
A) Amino acids listed are those for which a signal above background 
was measured. Asx is the combination of Asp and Asn, Glx is the 
combination of Gln and Glu. B) Amount of amino acid present in 
pmols. C) Amount of amino acid expressed as a percentage of the 
sum. D) Amount of amino acid expected based on sequence of 
BRD2. Two tryptophan residues in the BRD2 peptide were 
destroyed during the acid hydrolysis and derivatization of the 
resulting amino acids prior to amino acid analysis, which accounts for 
the remaining 4 % of the total picomoles of sample.
Negative stained EM images of BioBRD2 and BRD2 in lantha- num solution Figure 8
Negative stained EM images of BioBRD2 and BRD2 
in lanthanum solution. A) BioBRD2 alone; B) 2:1 mixture 
of BRD2:BioBRD2; C) 20:1 mixture of BRD2:BioBRD 2; D) 
40:1 mixture of BRD2:BioBRD2. These images at 30,000 × 
magnification on Formvar-coated nickel grids show the 
inverse relationship between the concentration of bioti-
nylated BRD2 and the length of filaments formed. BioBRD2 
does not form filaments in lanthanum solutions and it 
reduces the length and abundance of BRD2 filaments com-
pared to identical conditions with BRD2 alone.
Plot of the average hydrodynamic radius (nm) against the  amount of BioBRD2 (%) compared to unmodified BRD2 Figure 9
Plot of the average hydrodynamic radius (nm) 
against the amount of BioBRD2 (%) compared to 
unmodified BRD2. A 100% BioBRD2 sample represents a 
solution free of BRD2 while a 50% BioBRD2 solution corre-
sponds to a 1 to 1 mixture of the two peptides. Y-axis error 
bars represent the standard deviation between three samples 
for each data point. Note the inverse correlation between 
increase in hydrodynamic radius and decreasing amount of 
BioBRD2.
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gesting a removal of weakly bound lanthanum ions
(possibly between BRD2 monomers) leads to some
degree of filament dissociation. Unfortunately, elemental
analysis of these wash fractions yielded concentrations
below the detectable limit of La3+ by ICP-AEOS (less than
0.1 ppm or μM concentrations).
The BRD filaments are not amyloid fibrils
Finally, the BRD filaments were analyzed for their similar-
ity to amyloid fibrils. Two standard spectrometric assays
were used, thioflavin T binding [26] and congo red bind-
ing [27]. BRD2 filaments had much lower fluorescent
emission at 482 nm (3.0 × 104 AFU) compared to a sam-
ple of Aβ40 amyloid fibrils (1.95 × 105 AFU) in the pres-
ence of thioflavin T. In addition, BRD2 filaments did not
produce a characteristic spectral shift towards 550 nm
upon congo red binding compared to serum amyloid A
fibrils (data not shown). The A540nm/A480nm for BRD2 was
0.045 compared to 0.16 for serum amyloid A fibrils. Con-
trol experiments using Aβ-40 in the presence and absence
of 10 mM LaCl3 demonstrated that lanthanum had no
intrinsic affect on amyloid fibril staining using thioflavin
T and congo red (data not shown).
Discussion
It is clear that these BRD polypeptides have some very
interesting and unusual properties. In the presence of La3+
they form long, thin, unbranched filaments with some
tendency to associate side by side to form bundles up to
40 nm thick and/or become tangled. We propose a model
for these based on a simple head-to-tail repeating unit of
BRD monomers that interact via the N- and C-terminal
regions with lanthanum ions bound to the designed
metal-binding sites. Lanthanum ions may also interact
with charged side chains between the N and C termini of
two different monomers, effectively linking the BRD
monomers together. This model allows for the polymeri-
zation of the BRD monomer by the formation of very long
continuous parallel β-sheets. These long β-sheets can then
interact with more lanthanum ions via charged side
chains and form bridged interactions with other β-roll fil-
aments, allowing for the formation of filament bundles.
Branched filaments would be unlikely to form if this
model holds true as the head-to-tail interaction does not
allow for two BRD monomers to interact at the C termi-
nus of a single monomer. Experimental data support this
suggestion as branched filaments have not been observed
by EM.
The addition of EDTA causes the filaments to readily dis-
associate and dissolve. This is a novel feature as peptide
aggregates are often very hard to resolubilize. Amino acid
analysis proved that the filaments are proteinaceous, with
a profile that matches the composition of the BRD
polypeptides. Therefore, the observed increase in right
angle light scattering is not simply due to a precipitate of
insoluble lanthanum compounds. One explanation for
disassembly of the filaments in EDTA would be removal
of La3+ from the monomer interface thereby destabilizing
the structure of the building block. If this happened ran-
domly along the filament the internal breaks would
quickly cause filament disassembly. The exact amount of
EDTA required to disassociate the β-roll filaments is
unclear but based on right angle light scattering timedrive
data in Figure 4, EDTA begins to have an effect relatively
early in its introduction to the sample (observed as a
decrease in right angle light scattering) but it takes around
240 s for the signal to return to baseline. This is twice the
length of the lanthanum injection time course although
the lanthanum stock is 1 M whereas the EDTA stock is 0.5
M which suggests an equal amount of EDTA is required.
Presumably, EDTA would first bind any free La3+ then
begin to remove La3+ ions from the filaments leading to
disassociation. The dissolution of some of the BRD fila-
ments under washing conditions suggests that a portion
of La3+ is bound weakly, most likely the ions bound
between BRD monomers and any non-specifically bound
ions. The stability constant (Kstab) of the La3+-EDTA com-
plex is 5.01 × 1015 Mol-1 [28], and as the dissociation con-
stant (Kd) = 1/Kstab, the Kd for La3+-EDTA is 2.0 × 10-16 Mol-
1. This binding is 100,000 times tighter than that between
EDTA and Ca2+. EDTA therefore has such a strong affinity
for La3+ ions that it will likely outcompete the affinity of
La3+  for the designed metal-binding sites in the BRD
polypeptides. Even if the lanthanum were bound tightly
to the polypeptide, EDTA would be able to form stable
complexes and lead to dissociation of the BRD filaments.
The BRD filaments only form in the presence of peptide
and lanthanum ions. Several controls where carried out
using divalent and trivalent metal ions (Ca2+, Mg2+, Mn2+,
and Al3+) and none of these metals gave an increase in
right angle light scattering due to filament formation, as
shown in Figure 4C. Other lanthanoid metals were tested
(Ce3+, Nd3+, Sm3+ and Tb3+) and some of these gave small
right angle light scattering increases. However, no fila-
ments were visible by EM (data not shown). It is interest-
ing to note that studies on the R-module of AlgE4 from
Azotobactor vinelandii, where the lanthanide thulium was
used in place of calcium, gave a precipitate at 6 mM or
higher thulium [18]. Thulium ions were also shown to be
binding to negative residues on the surface of the R-mod-
ule and in the unordered C-terminal region. The precipi-
tate was not analyzed further so it is not known if protein
filaments formed.
Amino acid analysis and elemental analysis data suggest
that around 75 La3+ ions are present for every BRD mono-
mer and not all of the peptide and metal present in solu-
tion forms filamentous aggregates. A slightly lower ratioBMC Structural Biology 2007, 7:63 http://www.biomedcentral.com/1472-6807/7/63
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was obtained from right angle light scattering data but
lanthanum is clearly in excess and therefore cannot sim-
ply be binding just to the four designed calcium-binding
sites in the BRD polypeptides. Analysis of stained but
unwashed EM grids showed a huge amount of electron
density which was easily washed off by rinsing the grids in
water before placing them on the EM. This may be excess
lanthanum that precipitates with the filaments, artificially
raising the amount of lanthanum associated with the pep-
tide filaments.
The BRD filaments are similar in diameter and appearance
to some amyloid protofibrils [25] but do not always form
highly ordered bundles. The bundles that do form are not
as thick as those seen for amyloid under EM and atomic
force microscopy (AFM) [25,29]. There is also variability
in the length of the filaments. Filament length increases as
a function of time; longer growth times produce longer
fibrils. On a short time scale, the scattering of samples in
the presence of lanthanum would slowly increase until
the addition of EDTA was initiated, suggesting that the fil-
aments were increasing in size. On a longer time scale,
samples that were set up for EM showed a general increase
in filament length the longer they were incubated on the
EM grids prior to staining. This suggests the filaments are
growing from a nucleus and additional BRD monomers
are added to the ends of the filament nucleus. In addition,
the scattering responses of BRD2 polypeptides were larger
than those seen for BRD1 polypeptides at an identical
concentration. The BRD2 polypeptide is 16 amino acid
longer (~50% larger) than BRD1 and 1.3 kDa larger in
mass. The difference in size and mass between these two
polypeptides would be magnified in a filament where the
units repeat and could explain the higher scattering
responses for BRD2 filaments. The models we present in
Figure 6 fit the experimental data and the continual addi-
tion of further BRD polypeptides via N- to C-terminal
interactions could produce filaments that are hundreds of
nanometers in length. The model assumes the peptides do
adopt a β-roll-like conformation as the diameter of a sin-
gle filament (~3 nm) closely matches that of the β-roll
peptide model (3 nm) in Figure 2.
The modification of BRD2 with an N-terminal biotin res-
idue lends further support to our model of filament for-
mation. The modified peptide can clearly inhibit filament
formation and does not form filaments alone. Therefore,
the N terminus of the BRD peptide is important in the
aggregation process. The ability to exert some control over
filament length and abundance by altering the amount of
BioBRD2 is of great interest and practical application. This
capping strategy could be altered to have other modified
BRD polypeptides with biotin or other functional groups
positioned elsewhere on the BRD unit which would allow
for decoration of the filaments with other moieties such as
enzyme subunits, fluorescent tags or antibodies. The
degree of decoration could be controlled in an analogous
manner to the capping strategy. A higher proportion of
modified BRD monomers would lead to more decoration
and vice versa. In theory it is possible that a filament could
be grown with a core of BRD2 peptides, an N-terminal cap
and several different modified BRD polypeptides. Protein
and peptide-based nanomaterials are of great interest and
have many potential applications, several of which have
been reported recently [30-34].
The aggregation of β-sheet rich proteins is not uncommon
as β-strands are intrinsically insoluble [35] and nature has
evolved several ways in which to avoid the aggregation of
proteins containing β-sheets [36]. The de novo design of
soluble  β-sheet proteins has proven to be particularly
challenging but there have been some notable successes
[21,37-39]. With the challenges of designing soluble β-
sheet proteins in mind, it is unsurprising that many
designed β-sheet proteins form aggregates (either by mis-
folding or implicit design) and some of these are fibrillar
in nature [40-43]. It is also possible to convert a protein
that would normally from ordered aggregates into a solu-
ble monomeric from [44] or assembly can be blocked by
the addition of various inhibitors [45-47]. Our BRD
polypeptides are another example of a designed protein
that forms an ordered aggregate. However, they can be dis-
assembled simply by the addition of chelating agents such
as EDTA and the addition of a biotin residue at the N-ter-
minus can block filament polymerization.
In-register parallel β-sheet arrangements have been dem-
onstrated for several proteins [48-51]. However, these
folds do not closely resemble β-rolls as the β-strands of a
β-roll are not in-register. Prion protein fibrils have been
modelled as β-helical repeating units (similar to β-rolls
but the turn regions are less tight) but this model does not
stand up to scrutiny as well as the spiral model of prion
protein fibrils [52]. Similarly, Sup35 fibrils have also been
modelled as β-helices with parallel β-strands similar to
those found in β-rolls [53] but the model has been inval-
idated [54]. The β-roll model of HET-s fibrils from
Podospora anserina [4] is the most similar model but does
not rely on metal-binding and is not reversible. However,
there is evidence that metal ions, particularly Zn2+ and
Cu2+, are involved in amyloidogenesis and other related
pathways in neurodegenerative diseases [55,56].
In comparison to amyloid fibrils, the BRD filaments are of
similar size to amyloid protofilaments, presumably
because they share repeating parallel β-strand motifs, but
they do not stain with congo red of thioflavin T and they
do not associate into fibrils as readily. The BRD filaments
are also easily solubilised by the addition of EDTA.BMC Structural Biology 2007, 7:63 http://www.biomedcentral.com/1472-6807/7/63
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Since beginning this design project it is of interest to note
that our lab has discovered a hyperactive antifreeze pro-
tein from Antarctic lake bacterium, Marinomonas primory-
ensis, that appears to be similar to RTX toxin proteins and
alkaline protease from Pseudomonas aeruginosa. The pro-
tein is very large and contains several domains (unpub-
lished). The domain responsible for the very high
antifreeze protein activity contains a putative β-roll with
GGXGXDXUX repeats, that is very similar to the alkaline
protease β-roll template used to design the filament form-
ing BRD polypeptides. Antifreeze activity is only observed
in the presence of Ca2+ suggesting that the domain forms
a calcium-bound β-roll motif. The BRD polypeptides were
originally designed with the future goal of engineering an
antifreeze protein. At the time, no such β-roll AFP had
been discovered but our recent findings support the use of
a metal-binding β-roll peptide as a scaffold to design an
antifreeze protein.
Conclusion
In summary, polypeptides based on the calcium-binding
β-roll domain of alkaline protease from Pseudomonas aer-
uginosa were designed and synthesized. In the presence of
lanthanum ions, the polypeptides polymerized and
formed non-amyloid-like aggregates. Analysis of this phe-
nomenon by right angle light scattering and electron
microscopy confirmed the presence of protein filaments
several hundreds of nanometers in length but only 3 nm
in diameter. These filaments were only formed in the pres-
ence of La3+, no other metal ions tested could induce fila-
ment formation. A novel feature of these filaments is their
reversible nature caused by the addition of EDTA. In addi-
tion, modification of the N terminus of BRD2 with biotin
produced a capping effect whereby the length and abun-
dance of the filaments could be controlled by varying the
ratio of modified to unmodified peptide.
Methods
Peptide synthesis and purification
Peptides were prepared by solid-phase synthesis on a
PerSeptive Biosystems 9050 Plus peptide synthesizer, as
peptide-amides using PAL-PEG-PS resin (PerSeptive Bio-
systems). A coupling procedure, employing O-(7-azaben-
zotriazol-1-yl)-1,1,3,3-tetramethyluronium
hexafluorophosphate active esters of 9-fluorenylmethoxy-
carbonyl amino acids was used. The peptides were cleaved
from the resin with an 81:13:1:5 (v/v) mixture of trifluor-
oacetic acid, thioanisole, m-cresol, and ethanedithiol,
respectively, for 30 min at 25°C. The peptides were puri-
fied by C18 reversed-phase chromatography, and peptide
identity was confirmed by matrix-assisted laser desorp-
tion/ionization mass spectrometry (MALDI-MS) and
amino acid analysis. Peptide purity was assessed by ana-
lytical C18 reversed-phase chromatography using the
Pharmacia FPLC system. BioBRD2 was synthesized using
FMOC solid phase chemistry by Dr. Nam-Chaing Wang at
the Advanced Protein Technology Centre, The Hospital
for Sick Children, Toronto, ON, Canada. The peptide was
purified by HPLC as stated above.
Circular dichroism spectroscopy
Circular Dichroism measurements were performed on an
Aviv 62A DS Circular Dichroism Spectrometer. Spectra
were obtained using a 1 mm quartz cuvette at 25°C in
water or 10 mM HEPES pH 7.6. The peptide concentra-
tion for each spectra was 10 μM and the wavelength range
was 190–280 nm. All CD measurements are reported in
millidegrees.
1D NMR spectroscopy
1D NMR spectra were recorded on a Varian Inova 600
MHz NMR spectrometer equipped with a z-gradient HCN
probe. Acquisition parameters were: acquisition time 2 s;
sweep width 8000 Hz; recycle delay 2.5 s; number of scans
512; and a 90° pulse. Spectra are presented with a 0.5 Hz
line broadening for increased signal-to-noise. The BRD1
sample was added to 90% H2O/10% D2O to make an
approximately 0.5 mM solution, and the pH adjusted to
6.5. Calcium was titrated into the sample up to 128 mM.
Right angle light scattering timedrives
Right angle light scattering was measured using a Perkin
Elmer LS-50 luminescence spectrometer and FL WinLab
v3.0 software. Samples were excited at 320 nm and the
right angle light scattering at 320 nm at 90° to the excita-
tion beam was collected. Slit widths were set to 2.5 nm
and all experiments were carried out at room temperature
(~22°C). Samples were placed in a stirred 3 mL quartz flu-
orescent cuvette containing 20 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), pH 7.6 as a
buffer. At 200 s a solution of BRD polypeptide(s) was
injected into the cuvette usually giving a final concentra-
tion of 10 mM BRD polypeptide but other concentrations
were also used. At 500 s, a 1 M stock of lanthanum trichlo-
ride was injected using a syringe pump set to 4 μL/min for
a total of 120 s. At 1200 s, a 0.5 M stock solution of EDTA
was injected, also at 4 μL/min until the right angle light
scattering signal returned to the baseline.
Electron microscopy
Initial samples of the BRD1 and 2 aggregates were dried
for a period of a few days on charged Pioloform, carbon-
coated EM grids and then negative stained with 1 % phos-
photungstic acid. For subsequent EM images, negatively
stained fibrils were prepared by floating peptide solutions
(100 μM total peptide concentration, 10 mM La3+ in 20
mM HEPES, pH 7.6) on Formvar-coated Ni2+ EM grids
(Pelco No. 160, Redding, CA, USA). These solutions were
incubated for 3–5 days. After the grids were blotted and
air-dried, the samples were stained with 1 % (w/v) phos-BMC Structural Biology 2007, 7:63 http://www.biomedcentral.com/1472-6807/7/63
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photungstic acid. Electron microscopy images of the pep-
tides were acquired on a Hitachi H-7000 transmission
electron microscope (TEM) operated with an accelerating
voltage of 75 kV at 30,000 × magnification.
Amino acid analysis and elemental analysis
Amino acid analysis was performed at the Advanced Pro-
tein Technology Centre, The Hospital for Sick Children,
Toronto, ON, Canada. Trace element analysis for La3+
was carried out on samples using inductively coupled
plasma atomic emission Spectra (ICP-AEOS) at ANALEST,
Department of Chemistry, University of Toronto, ON,
Canada.
BRD polypeptide modeling
The BRD1 and 2 models were constructed and minimized
using SYBYL 6.0. The structures of BRD1 and 2 were
threaded onto the alkaline protease β-roll domain using
Swiss-PdbViewer and SWISS-MODEL. The models of the
docked BRD2 filaments were generated using HEX. Ray
traced figures in this paper were generated using PyMol
v0.99.
Dynamic light scattering
DLS data were collected using a Wyatt DynaPro Titan
molecular sizing system at 25°C using Dynamics software
v5.26.38. The system was calibrated using ultrapure water
and 2 mg/mL bovine serum albumin (BSA). Samples were
prepared as above (100 μM final protein concentration)
and analyzed in a 12 μL quartz cuvette. A total of 25 data
points were collected for calculation of the average hydro-
dynamic radius for each sample.
Thioflavin T fluorescence scans
Samples of BRD2 filaments (100 μM final peptide con-
centration, 10 mM La3+) and Aβ-40 amyloid fibrils (with
and without 10 mM La3+) were assayed for thioflavin T
(ThT) binding (0.035 mg/mL) using a Perkin Elmer LS-50
luminescence spectrometer and FL WinLab v3.0 software.
Samples were excited at 455 nm in stirred 1 mL quartz flu-
orescent cuvettes and spectra were collected between 460
nm and 560 nm (Slit widths = 2.5 nm).
Congo Red UV/Visible spectrometry
Samples of BRD2 (100 μM final peptide concentration)
with and without La3+ (10 mM final concentration) and
serum amyloid A fibrils purified from rat pancreas were
allowed to bind to freshly prepared Congo red (7 μM)
overnight in a 1 mL disposable cuvette. The samples were
mixed and the spectrum from 400 nm to 600 nm was
recorded on a Cary 50 Bio UV spectrophotometer running
Cary WinUV v2.0 software.
Abbreviations
BRD1 and 2: β-roll designed polypeptides 1 and 2; CAST:
full length calpastatin; CD: circular dichroism; DLS:
dynamic right angle light scattering; EDTA: ethylenedi-
aminetetraacetic acid; EM: electron microscopy; HEPES:
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid;
NMR: nuclear magnetic resonance; PGAL: 6-phospho-β-
galactosidase; RTX: repeat-in-toxin
Competing interests
The author(s) declares that there are no competing inter-
ests.
Authors' contributions
RLC, MMT and PLD designed the BRD polypeptides. Pep-
tides were synthesized and purified by MG and AC. CD
data were collected by MG, MMT and AC. 1D NMR data
were collected by MED and BDS. Right angle light scatter-
ing and dynamic light scattering data were collected by
AJS. EM images were collected by AJS and RJO. Congo red
and thioflavin T data were collected by AJS, DAB and AC.
The model of the BRD2 filaments was prepared by RLC.
All the authors read and approved the manuscript.
Acknowledgements
This research was principally funded by the Government of Canada's Net-
work of Centers of Excellence program supported by the Canadian Insti-
tute for Health Sciences and the Natural Sciences and Engineering Research 
Council through PENCE (the Protein Engineering Network of Centers of 
Excellence). Additional funding was from CIHR to PLD, who holds a Can-
ada Research Chair in Protein Engineering. We thank Judy Vanhorne for 
help with EM studies.
References
1. Kobe B, Kajava AV: When protein folding is simplified to pro-
tein coiling: the continuum of solenoid protein structures.
Trends Biochem Sci 2000, 25:509-515.
2. Jenkins J, Pickersgill R: The architecture of parallel beta-helices
and related folds.  Prog Biophys Mol Biol 2001, 77:111-175.
3. Sprang SR: On a (beta-) roll.  Trends Biochem Sci 1993, 18:313-314.
4. Ritter C, Maddelein ML, Siemer AB, Luhrs T, Ernst M, Meier BH,
Saupe SJ, Riek R: Correlation of structural elements and infec-
tivity of the HET-s prion.  Nature 2005, 435:844-848.
5. Sen A, Baxa U, Simon MN, Wall JS, Sabate R, Saupe SJ, Steven AC:
Mass analysis by scanning transmission electron microscopy
and electron diffraction validate predictions of stacked beta-
solenoid model of HET-s prion fibrils.  J Biol Chem 2007,
282:5545-5550.
6. Baumann U: Crystal structure of the 50 kDa metallo protease
from Serratia marcescens.  J Mol Biol 1994, 242:244-251.
7. Baumann U, Wu S, Flaherty KM, McKay DB: Three-dimensional
structure of the alkaline protease of Pseudomonas aerugi-
nosa: a two-domain protein with a calcium binding parallel
beta roll motif.  Embo J 1993, 12:3357-3364.
8. Hege T, Baumann U: Protease C of Erwinia chrysanthemi: the
crystal structure and role of amino acids Y228 and E189.  J
Mol Biol 2001, 314:187-193.
9. Coote JG: Structural and functional relationships among the
RTX toxin determinants of gram-negative bacteria.  FEMS
Microbiol Rev 1992, 8:137-161.
10. Lally ET, Golub EE, Kieba IR, Taichman NS, Rosenbloom J, Rosen-
bloom JC, Gibson CW, Demuth DR: Analysis of the Actinobacil-
lus actinomycetemcomitans leukotoxin gene. Delineation of
unique features and comparison to homologous toxins.  J Biol
Chem 1989, 264:15451-15456.BMC Structural Biology 2007, 7:63 http://www.biomedcentral.com/1472-6807/7/63
Page 13 of 13
(page number not for citation purposes)
11. Lalonde G, McDonald TV, Gardner P, O'Hanley PD: Identification
of a hemolysin from Actinobacillus pleuropneumoniae and
characterization of its channel properties in planar phos-
pholipid bilayers.  J Biol Chem 1989, 264:13559-13564.
12. Strathdee CA, Lo RY: Extensive homology between the leuko-
toxin of Pasteurella haemolytica A1 and the alpha-hemolysin
of Escherichia coli.  Infect Immun 1987, 55:3233-3236.
13. Rogel A, Schultz JE, Brownlie RM, Coote JG, Parton R, Hanski E: Bor-
detella pertussis adenylate cyclase: purification and charac-
terization of the toxic form of the enzyme.  Embo J 1989,
8:2755-2760.
14. Schmidt H, Maier E, Karch H, Benz R: Pore-forming properties of
the plasmid-encoded hemolysin of enterohemorrhagic
Escherichia coli O157:H7.  Eur J Biochem 1996, 241:594-601.
15. Welch RA, Forestier C, Lobo A, Pellett S, Thomas W Jr., Rowe G:
The synthesis and function of the Escherichia coli hemolysin
and related RTX exotoxins.  FEMS Microbiol Immunol 1992,
5:29-36.
16. Kwon HJ, Haruki M, Morikawa M, Omori K, Kanaya S: Role of
repetitive nine-residue sequence motifs in secretion, enzy-
matic activity, and protein conformation of a family I.3
lipase.  J Biosci Bioeng 2002, 93:157-164.
17. Angkawidjaja C, Paul A, Koga Y, Takano K, Kanaya S: Importance of
a repetitive nine-residue sequence motif for intracellular sta-
bility and functional structure of a family I.3 lipase.  FEBS Lett
2005, 579:4707-4712.
18. Aachmann FL, Svanem BI, Guntert P, Petersen SB, Valla S, Wimmer
R: NMR structure of the R-module: a parallel beta-roll subu-
nit from an Azotobacter vinelandii mannuronan C-5 epime-
rase.  J Biol Chem 2006, 281:7350-7356.
19. Lilie H, Haehnel W, Rudolph R, Baumann U: Folding of a synthetic
parallel beta-roll protein.  FEBS Lett 2000, 470:173-177.
20. Ringler P, Schulz GE: Self-assembly of proteins into designed
networks.  Science 2003, 302:106-109.
21. Cochran AG, Skelton NJ, Starovasnik MA: Tryptophan zippers:
stable, monomeric beta -hairpins.  Proc Natl Acad Sci U S A 2001,
98:5578-5583.
22. Furie B, Eastlake A, Schechter AN, Anfinsen CB: The interaction of
the lanthanide ions with staphylococcal nuclease.  J Biol Chem
1973, 248:2821-2825.
23. Hosfield CM, Elce JS, Davies PL, Jia Z: Crystal structure of calpain
reveals the structural basis for Ca(2+)-dependent protease
activity and a novel mode of enzyme activation.  Embo J 1999,
18:6880-6889.
24. Zhang H, Johnson P: Inhibition of calpains by calmidazolium
and calpastatin.  J Enzyme Inhib 1988, 2:163-166.
25. Serpell LC: Alzheimer's amyloid fibrils: structure and assem-
bly.  Biochim Biophys Acta 2000, 1502:16-30.
26. LeVine H 3rd: Quantification of beta-sheet amyloid fibril struc-
tures with thioflavin T.  Methods Enzymol 1999, 309:274-284.
27. Klunk WE, Jacob RF, Mason RP: Quantifying amyloid by congo
red spectral shift assay.  Methods Enzymol 1999, 309:285-305.
28. Spencer H: Studies of the effect of chelating agents in man.
Annals of the New York Academy of Sciences 1966, 88:435-449.
29. Arimon M, Diez-Perez I, Kogan MJ, Durany N, Giralt E, Sanz F, Fern-
andez-Busquets X: Fine structure study of Abeta1-42 fibrillo-
genesis with atomic force microscopy.  Faseb J 2005,
19:1344-1346.
30. Zheng J, Zanuy D, Haspel N, Tsai CJ, Aleman C, Nussinov R: Nanos-
tructure Design Using Protein Building Blocks Enhanced by
Conformationally Constrained Synthetic Residues.  Biochemis-
try 2007, 46:1205-1218.
31. Graveland-Bikker JF, Schaap IA, Schmidt CF, de Kruif CG: Structural
and mechanical study of a self-assembling protein nanotube.
Nano Lett 2006, 6:616-621.
32. Reches M, Gazit E: Casting metal nanowires within discrete
self-assembled peptide nanotubes.  Science 2003, 300:625-627.
33. Vauthey S, Santoso S, Gong H, Watson N, Zhang S: Molecular self-
assembly of surfactant-like peptides to form nanotubes and
nanovesicles.  Proc Natl Acad Sci U S A 2002, 99:5355-5360.
34. Lee CC, MacKay JA, Frechet JM, Szoka FC: Designing dendrimers
for biological applications.  Nat Biotechnol 2005, 23:1517-1526.
35. Salemme FR: Structural properties of protein beta-sheets.  Prog
Biophys Mol Biol 1983, 42:95-133.
36. Richardson JS, Richardson DC: Natural beta-sheet proteins use
negative design to avoid edge-to-edge aggregation.  Proc Natl
Acad Sci U S A 2002, 99:2754-2759.
37. Griffiths-Jones SR, Maynard AJ, Searle MS: Dissecting the stability
of a beta-hairpin peptide that folds in water: NMR and
molecular dynamics analysis of the beta-turn and beta-
strand contributions to folding.  J Mol Biol 1999, 292:1051-1069.
38. Yan Y, Erickson BW: Engineering of betabellin 14D: disulfide-
induced folding of a beta-sheet protein.  Protein Sci 1994,
3:1069-1073.
39. West MW, Hecht MH: Binary patterning of polar and nonpolar
amino acids in the sequences and structures of native pro-
teins.  Protein Sci 1995, 4:2032-2039.
40. Lim A, Makhov AM, Bond J, Inouye H, Connors LH, Griffith JD, Erick-
son BW, Kirschner DA, Costello CE: Betabellins 15D and 16D,
de Novo designed beta-sandwich proteins that have amy-
loidogenic properties.  J Struct Biol 2000, 130:363-370.
41. West MW, Wang W, Patterson J, Mancias JD, Beasley JR, Hecht MH:
De novo amyloid proteins from designed combinatorial
libraries.  Proc Natl Acad Sci U S A 1999, 96:11211-11216.
42. Lopez De La Paz M, Goldie K, Zurdo J, Lacroix E, Dobson CM,
Hoenger A, Serrano L: De novo designed peptide-based amy-
loid fibrils.  Proc Natl Acad Sci U S A 2002, 99:16052-16057.
43. Topilina NI, Higashiya S, Rana N, Ermolenkov VV, Kossow C, Carlsen
A, Ngo SC, Wells CC, Eisenbraun ET, Dunn KA, Lednev IK, Geer RE,
Kaloyeros AE, Welch JT: Bilayer fibril formation by genetically
engineered polypeptides: preparation and characterization.
Biomacromolecules 2006, 7:1104-1111.
44. Wang W, Hecht MH: Rationally designed mutations convert de
novo amyloid-like fibrils into monomeric beta-sheet pro-
teins.  Proc Natl Acad Sci U S A 2002, 99:2760-2765.
45. Yan LM, Tatarek-Nossol M, Velkova A, Kazantzis A, Kapurniotu A:
Design of a mimic of nonamyloidogenic and bioactive human
islet amyloid polypeptide (IAPP) as nanomolar affinity inhib-
itor of IAPP cytotoxic fibrillogenesis.  Proc Natl Acad Sci U S A
2006, 103:2046-2051.
46. Sadowski MJ, Pankiewicz J, Scholtzova H, Mehta PD, Prelli F, Quarter-
main D, Wisniewski T: Blocking the apolipoprotein E/amyloid-
beta interaction as a potential therapeutic approach for
Alzheimer's disease.  Proc Natl Acad Sci U S A 2006,
103:18787-18792.
47. Sciarretta KL, Gordon DJ, Meredith SC: Peptide-based inhibitors
of amyloid assembly.  Methods Enzymol 2006, 413:273-312.
48. Antzutkin ON, Balbach JJ, Leapman RD, Rizzo NW, Reed J, Tycko R:
Multiple quantum solid-state NMR indicates a parallel, not
antiparallel, organization of beta-sheets in Alzheimer's beta-
amyloid fibrils.  Proc Natl Acad Sci U S A 2000, 97:13045-13050.
49. Kishimoto A, Hasegawa K, Suzuki H, Taguchi H, Namba K, Yoshida
M: beta-Helix is a likely core structure of yeast prion Sup35
amyloid fibers.  Biochem Biophys Res Commun 2004, 315:739-745.
50. Margittai M, Langen R: Template-assisted filament growth by
parallel stacking of tau.  Proc Natl Acad Sci U S A 2004,
101:10278-10283.
51. Tycko R: Molecular structure of amyloid fibrils: insights from
solid-state NMR.  Q Rev Biophys 2006, 39:1-55.
52. Demarco ML, Silveira J, Caughey B, Daggett V: Structural Proper-
ties of Prion Protein Protofibrils and Fibrils: An Experimen-
tal Assessment of Atomic Models.  Biochemistry 2006,
45:15573-15582.
53. Krishnan R, Lindquist SL: Structural insights into a yeast prion
illuminate nucleation and strain diversity.  Nature 2005,
435:765-772.
54. Shewmaker F, Wickner RB, Tycko R: Amyloid of the prion
domain of Sup35p has an in-register parallel beta-sheet
structure.  Proc Natl Acad Sci USA 2006, 103:19754-19759.
55. Giese A, Levin J, Bertsch U, Kretzschmar H: Effect of metal ions
on de novo aggregation of full-length prion protein.  Biochem
Biophys Res Commun 2004, 320:1240-1246.
56. Stellato F, Menestrina G, Serra MD, Potrich C, Tomazzolli R, Meyer-
Klaucke W, Morante S: Metal binding in amyloid beta-peptides
shows intra- and inter-peptide coordination modes.  Eur Bio-
phys J 2006, 35:340-351.